Our previous studies defined an Alopecia Areata Disease Activity Index (ALADIN) biomarker for response to treatment (Xing et al., 2014), which monitors three distinct gene expression signatures, one of which is the IFN response. The gene discussed is IFNA1; the disease is alopecia areata.